AirSculpt Technologies, Inc.

Greetings and welcome to the AirSculpt Technologies Inc. third quarter 2023 earnings call. At this time, all participants are on a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Dennis Dean of AirSculpt. Thank you. You may begin.

Good morning, everyone, and thanks for joining us to discuss AirSculpt Technologies results for the third quarter. Joining me on the call today is the company's founder and executive chairman, Dr. Aaron Rollins, and chief executive officer, Todd Magazine. Before we begin, I would like to remind you that this conference call may include forward-looking statements. These statements may include our future expectations regarding financial results and guidance, market opportunities, and our growth. Risk and uncertainties that may impact these statements and could cause actual future results to differ materially from currently projected results are described in this morning's press release and the reports we will file with the SEC, all of which can be found on our website at investors.elitebodysculpture.com. We undertake no obligation to revise or update any forward-looking statements or information except as required by law. During our call today, we will also reference certain non-GAAP financial measures We use non-GAAP measures in some of our financial discussions as we believe they more accurately represent the true operational performance and underlying results of our business. A reconciliation of these measures can be found in our earnings release as filed last night and in our most recent 10-Q when filed, which will also be available on our website. With that, I'll turn the call over to Erin.

Thank you, Dennis. Good morning to everyone and thanks for joining the call. I'm very pleased with our strong third quarter results and our team's ability to execute with excellence on a global basis. We are also making great strides in growing brand awareness for Airscope and believe the investments we are making now are important to our future success. We look forward to a strong finish to 2023 and continuing to drive long-term shareholder value. On the innovation front, as I mentioned during the last quarter call, We are early in the rollout of Aeroscope Lift, a facial fat transfer procedure that can eliminate wrinkles, restore lost volume to areas of the face, and provide more volume in lips. As you know, the broader filler market is over $4 billion, which expands our already significant TAM to over $11 billion. We have started the rollout of Aeroscope Lift in about a third of our centers, including London, and will continue to expand it to the rest of the centers over the coming months as we train up our doctors and educate our sales and marketing teams. While we are early in the process, we expect a meaningful impact in 2024. Overall, our team is delivering consistent performance and executing on our key growth areas. Our strategy continues to focus on strengthening the Airscope brand, accelerating our store openings, and further enhancing our profitability as we scale our business both domestically and internationally. With that, let me now turn things over to Todd.